RxDoctor Payments Data

Kevin Knight, APRN

Family · Lagrange, GANPI 1588106009

Payments from drug & device makers

$1,089in general payments, 2019–2025

Across 61 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$500
  • Exact Sciences$172
  • Amgen$120
  • Dynavax Technologies Corporation$60
  • Globus Medical$48
  • Pfizer$47
  • plus $143 from 5 others

What the payments were for

  • Food & beverage$1,089100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,089 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$13,986
Medicare patients
67
Services billed
155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$56,087
JardianceEmpagliflozin22$27,605
MounjaroTirzepatide11$22,646
FarxigaDapagliflozin Propanediol13$21,735
TrulicityDulaglutide20$21,139
EliquisApixaban21$12,073
TradjentaLinagliptin11$10,931
Atorvastatin Calcium158$1,165
Losartan Potassium106$1,086
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,079
Omeprazole74$987
Levothyroxine Sodium109$970
Amlodipine Besylate219$830
Fluticasone Propionate87$808
Diclofenac Sodium30$791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$500$56,08750 claims
Lilly USA, LLCMounjaro, Trulicity$37$43,78631 claims
AstraZenecaFarxiga$22$21,73513 claims
PfizerEliquis$47$12,07321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,258 family providers in Georgia.

Other family in Lagrange

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →